Predictive Model for Pathologic Complete Response to Preoperative Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

YANG Yalan,ZONG Shanggang,WANG Feng

DOI: https://doi.org/10.3969/j.issn.1004-437x.2023.08.002

2023-01-01

Abstract:Objective To investigate the predictors of pathologic complete response（pCR） after preoperative neoadjuvant immunochemotherapy（nICT） in locally advanced esophageal squamous cell carcinoma（ESCC）, and to construct a nomogram model for predicting pCR after nICT.Methods The clinical data of locally advanced ESCC patients who underwent radical surgery after nICT in the First Affiliated Hospital of Zhengzhou University from February 2020 to April 2022 were retrospectively collected. The independent influencing factors of pCR was analyzed, and then a predictive nomogram was established. The Calibration curve was performed to evaluate its consistency from actual results, the area under curve（AUC） of the receiver operating characteristic（ROC） curve to evaluate the prediction discrimination of the model, and the decision curve analysis（DCA） to evaluate its clinical validity.Results A total of 131 patients with locally advanced ESCC were enrolled, among whom 33（25.20%） achieved pCR. Multivariate logistic analysis showed that clinical TNM stage, prognostic nutritional index（PNI）, lymphocyte to monocyte ratio（LMR） and carcinoembryonic antigen（CEA） were independent factors for pCR. The calibration curves showed good consistency. The AUC of this model was 0.81（95% CI: 0.719-0.896）, and DCA showed that the nomogram had clinical application value.Conclusion The model based on the four predictors of clinical TNM stage, PNI, LMR and CEA is helpful for individualized prediction of pCR after nICT in patients with locally advanced ESCC, which is of great significance for distinguishing and selecting suitable locally advanced ESCC patients for neoadjuvant therapy.